CSF1 and neoplasm: Overall, despite consistent reduction in TAM content in primary tumors in the various tumor models discussed above, the effects of M-CSF or M-CSFR blockade and consequent TAM attenuation on primary tumor growth seem to be quite variable, depending on the tumor model and the blocking agents used, and thus do not seem to correlate with TAM depletion per se.